20.6 C
New York
Thursday, June 18, 2026

Tag: progress

ASHEBORO, N.C., June 11, 2026 /PRNewswire/ -- Technimark, a global leader in plastic injection molding for healthcare, consumer packaging, and industrial markets, today announced...

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.

Victoria’s Secret & Co. Shareholders Decisively Re-Elect All Nine Company Director Nominees

Outcome reflects strong shareholder support for full Board, Company’s Path to Potential strategy and continued momentum under CEO Hillary Super

M&T Bank and The Florida Bar Renew Relationship to Expand Access to the M&T Bank Nota Platform

Enhanced platform reflects continued momentum, user-informed innovation and growing adoption among attorneysBUFFALO, N.Y. and TALLAHASSEE, Fla., June 11, 2026 /PRNewswire/ -- M&T Bank (NYSE:MTB)...

Fluence Releases Fiscal Year 2025 Sustainability Report

Report details progress in operational transparency and responsible business practices
Report details progress in operational transparency and responsible business practices

Tronox Issues 2025 Sustainability Report

STAMFORD, Conn., June 11, 2026 /PRNewswire/ -- Tronox Holdings plc (NYSE:TROX) ("Tronox" or the "Company"), the world's leading integrated manufacturer of titanium dioxide pigment, announced...

DeFi Development Corp. to Host X Spaces Event: “DFDV May 2026 Recap & AMA”

BOCA RATON, FL, June 11, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced it will host its May 2026 Business Recap & Ask Me Anything (“AMA”) today, June 11, 2026, at 11:00 AM ET via X Spaces.

Prairie Operating Co. Reaffirms $475 Million Credit Facility and Advances Series F Preferred Refinancing Initiatives

HOUSTON, TX, June 11, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced a series of actions that further strengthen the Company’s financial position, enhance liquidity, and continue to reduce potential shareholder dilution associated with the Company’s Series F Convertible Preferred Stock.

FPX Nickel Provides Environmental Assessment Progress Update – Confirmation of Federal Assessment for Baptiste and Coordinated Federal and Provincial Review

VANCOUVER, BC, June 11, 2026 /CNW/ - FPX Nickel Corp. (TSXV: FPX) (OTCQX: FPOCF) ("FPX" or the "Company") acknowledges that, as previously anticipated, the Impact Assessment...

Compass Diversified Announces CEO Succession Plan

Co-Founder and Chief Executive Officer Elias Sabo to Retire at Year End

Energy Fuels Expects to Achieve Full-Year Uranium Production Guidance by Mid-Year

Mid-year update highlights strong execution across the Company's U.S. uranium operations, with an expected 1.6 million pounds of finished U3O8 produced from January through...

Energy Fuels Expects to Achieve Full-Year Uranium Production Guidance by Mid-Year

Mid-year update highlights strong execution across the Company's U.S. uranium operations, with an expected 1.6 million pounds of finished U3O8 produced from January through...

Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India

Greenfield facility in Madhya Pradesh to support 'Make in India' vision and strengthen Haleon's commitment to delivering better everyday healthStrategic oral health-focused site designed...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgress